MedTrace Logo

Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia

NCT07735208 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-07-29

No results posted yet for this study

Summary

This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and improves patient-centered outcomes compared with usual oncologist-directed care in adults aged 60 years and older with newly diagnosed AML.

Conditions

Interventions

DRUG

GA-directed treatment regimens

Fit, vulnerable, and frail patients will receive predefined regimens based on their GA results.

Sponsors & Collaborators

  • Rising Tide Foundation

    collaborator OTHER

  • University of Rochester

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-01
Primary Completion
2031-11-30
Completion
2031-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07735208 on ClinicalTrials.gov